Effect of the high-affinity estrogen receptor ligand ICI 182,780 on the rat tibia

Endocrinology

Volumn 139, Issue 9, 1998, Pages 3736-3742

  Sibonga, Jean D ^a   Dobnig, Harald ^a   Harden, Ryan M ^a   Turner, Russell T ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTROGEN; FULVESTRANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BODY GROWTH; BODY WEIGHT; BONE TURNOVER; CELL GROWTH; CHOLESTEROL BLOOD LEVEL; ESTRADIOL BLOOD LEVEL; FEMALE; LIGAND BINDING; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; STATISTICAL ANALYSIS; TARGET CELL; TIBIA; UTERUS WEIGHT;

EID: 0031730275     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.9.6172     Document Type: Article

References (44)

1. Evans GL, Turner RT 1995 Tissue-selective actions of estrogen analogs. Bone [Suppl] 17:181S-190S
2. Wakeling AE, Bowler J 1987 Steroidal pure antiestrogens. J Endocrinol 112:R7-R10
3. Wakeling AE, Dukes M, Bowler J 1991 A potent specific pure antiestrogen with clinical potential. Cancer Res 51:3867-3873
4. Wakeling AE 1993 The future of new pure antiestrogens in clinical breast cancer. Breast Cancer Res Treat 25:1-9
5. Falwell SE, White R, Hoare S, Syndenham M, Page M, Parker MG 1990 Inhibition of estrogen receptor DNA binding by the "pure" antiestrogen ICI 163,384 appears to be mediated by impaired receptor dimerization. Proc Natl Acad Sci USA 87:6883-6887
6. McDonnell DP, Clemm DL, Hermann T, Goldman ME, Pike JW 1995 Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol 9:659-669
7. Smith TJ, Hillner BE 1993 The efficacy and cost-effectiveness of adjuvant therapy of early breast cancer in premenopausal women. J Clin Oncol 11:771-776
8. Santen RJ, Manni A, Harvey H, Redmond C 1990 Endocrine treatment of breast cancer in women. Endocr Rev 11:221-265
9. Jordan VG 1990 Long-term adjuvant tamoxifen therapy for breast cancer. Breast Cancer Res Treat 15:125-136
10. Love RR 1989 Tamoxifen therapy in premenopausal breast cancer: biology, efficacy and side effects. J Clin Oncol 7:803-815
11. Wiseman LR, Johnson MD, Wakeling AE 1993 Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells. Eur J Cancer 29A:2256-2264
12. Wakeling AE, Bowler J 1988 Novel antioestrogens without partial agonist activity. J Steroid Biochem 31:654-658
13. Tzukerman MT, Esty A, Santiso-Mere D, Danielian P, Parker MG, Stein RB, Pike JW, McDonnell DP 1994 Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol 8:21-30
14. Kuiper G, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S, Gustafsson J 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138:863-870
15. Gallagher A, Chambers TJ, Tobias JH 1993 The estrogen antagonist ICI 182,780 reduces cancellous bone volume in female rats. Endocrinology 133:2787-2791
16. Turner RT, Riggs BL, Spelsberg TC 1994 Skeletal effects of estrogen. Endocr Rev 15:275-300
17. Sibonga JD, Evans GL, Hauck ER, Bell NH, Turner RT 1996 Ovarian status influences the skeletal effects of tamoxifen in adult rats. Breast Cancer Res Treat 41:71-79
18. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: standardization of nomenclature, symbols, and units. J Bone Miner Res 2:595-610
19. Parfitt AM, Mathews CHE, Villanueva AR, Kleerekoper M, Frame B, Rao DS 1983 Relationships between surface, volume and thickness of iliac trabecular bone in aging and osteoporosis: implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 72:1396-1409
20. Lundeen SG, Carver JM, McKean M, Winneker RC 1997 Characterization of the ovariectomized rat model for the evaluation of estrogen effects on plasma cholesterol levels. Endocrinology 138:1552-1558
21. Kalu DN 1984 Evaluation of pathogenesis of skeletal changes in ovariectomized rats. Endocrinology 115:507-512
22. Evans GL, Bryant HU, Magee DE, Sato M, Turner RT 1996 The effects of raloxifene on tibia histomorphometry in ovariectomized rats. Endocrinology 134:2283-2288
23. Turner RT, Vandersteenhoven JJ, Bell NH 1987 The effect of ovariectomy and 17β-estradiol on cortical bone histomorphometry in growing rats. J Bone Miner Res 2:115-122
24. Turner RT, Wakley GK, Hannon KS, Bell NH 1987 Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats. J Bone Miner Res 2:449-456
25. Roy EJ, Maass CA, Wade GN 1977 Central action and a special comparison of the estrogenic effects of an antiestrogen on eating and body weight. Physiol Behav 18:137-140
26. Wakeling AE 1995 Tissue-specific actions of antioestrogens. Mutat Res 333:45-49
27. Jimenez MA, Magee DE, Bryant HU, Turner RT 1997 Clomiphene prevents cancellous bone loss from tibia of ovariectomized rats. Endocrinology 138:1794-1800
28. Ke HZ, Simmons HA, Pirie CM, Crawford DT, Thompson DD 1995 Droloxifene, a new estrogen antagonist/agonist prevents bone loss in ovariectomized rats. Endocrinology 136:2435-2441
29. Wronski TJ, Lowry PL, Walsh CC, Ignaszewski LA 1985 Skeletal alterations in ovariectomized rats. Calcif Tissue Int 37:324-328
30. Wronski TJ, Walsh CC, Ignaszewski LA 1986 Histologic evidence for osteopenia and increased bone turnover in ovariectomized rats. Bone 7:119-123
31. Turner RT, Hannon KS, Demers L, Buchanan J, Bell NH 1989 The differential effects of gonadal insufficiency on bone histomorphometry in male and female rats. J Bone Miner Res 4:557-563
32. Turner RT, Evans GL, Wakley GK 1993 Mechanism of action of estrogen on cancellous bone balance in tibiae of ovariectomized growing rats: inhibition of indices of formation and resorption. J Bone Miner Res 8:359-366
33. Wronski TJ, Cintron M, Doherty AL, Dann LM 1988 Estrogen treatment prevents osteopenia, and depresses bone turnover in ovariectomized rats. Endocrinology 123:681-686
34. Turner RT, Evans GL, Wakley GK 1994 Reduced chondroclast differentiation results in increased cancellous bone volume in estrogen-treated growing rats. Endocrinology 134:461-466
35. Hunziker EB 1988 Growth plate structure and function. Pathol Immunopathol Res 7:9-13
36. Parfitt AM 1983 The physiological and clinical significance of bone histomorphometric data. In: Recker RR (ed) Bone Histomorphometry. CRC Press, Inc, Boca Raton, pp 143-223
37. Erben RG 1996 Trabecular and endocortical bone surfaces in the rat: modeling or remodeling? Anat Rec 246:39-46
38. Kalu DN, Liu CC, Salerno E, Hollis B, Echon R, Ray M 1991 Skeletal response of ovariectomized rats to low and high doses of 17β-estradiol. Bone Miner 14:175-187
39. Westerlind KC, Wronski TJ, Ritman EL, Luo Z, An K, Bell NH, Turner RT 1997 Estrogen regulates the rate of bone turnover but bone balance in ovariectomized rats is modulated by prevailing mechanical strain. Proc Natl Acad Sci USA 94:4199-4204
40. Szego CM 1984 Mechanisms of hormone action: parallels in receptor-mediated signal propagation for steroid and receptor-mediated signal propagation for steroid and peptide effectors. Life Sci 35:2383-2396
41. Kidder LS, Zhang M, Wronski TJ, Turner RT Estrogen results in rapid, differential regulation of immediate response, growth factor, and matrix protein genes in bone and uterus of growing rats. Program of the 79th Annual Meeting of The Endocrine Society, Minneapolis MN, 1997, p 547
42. Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson JA, Kushner PJ, Scanlan TS 1997 Differential ligand activation of estrogen receptors Era and Erβ at AP1 sites. Science 277:1508-1510
43. Yang NN, Venugopalan M, Hardikar S, Glasebrook A 1996 Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene. Science 273:1222-1225
44. Montano MM, Katzenellenbogen BS 1997 The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens. Proc Natl Acad Sci USA 94:2581-2586